Could cause temporary or reversible harm; serious harm is unlikely.
Temperature Abuse
| Brand name | CIPROFLOXACIN AND DEXAMETHASONE |
| Generic name | CIPROFLOXACIN AND DEXAMETHASONE |
| Active ingredient(s) | CIPROFLOXACIN HYDROCHLORIDE, DEXAMETHASONE |
| Distributed by / for | Sandoz, Inc., Princeton, NJ |
| NDC | 0781-6186-67 |
| Full product label | Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67 |
| Recalling firm | Sandoz Inc |
| Distribution | Product was distributed to one consignee in CA. |
| Quantity | 1,680 bottles |
| Recall initiated | 2025-08-13 |
| Report date | 2025-09-17 |
| Recall completed | — |
| Recall number | D-0626-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗